APOE-ε2 and APOE-ε4 Correlate With Increased Amyloid Accumulation in Cerebral Vasculature

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works

An Introduction to Categorical Data Analysis

Agresti, A. (2006) · Wiley series in probability and statistics · doi:10.1002/0470114754 · Cited by 6,699 · see citing works

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · see citing works

The role of apolipoprotein E in Alzheimer's disease

Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · see citing works

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525 · see citing works

Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397 · see citing works

Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions

William Rebeck, G., Reiter, J. S., Strickland, D. K., & Hyman, B. T. (1993) · Neuron · doi:10.1016/0896-6273(93)90070-8 · Cited by 1,107 · see citing works

Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study

Vonsattel, J. P. G., Myers, R. H., Tessa Hedley‐Whyte, E., Ropper, A. H., Bird, E. D., & Richardson, E. P. (1991) · Annals of Neurology · doi:10.1002/ana.410300503 · Cited by 662 · see citing works

Cerebral amyloid angiopathy in the elderly

Viswanathan, A., & Greenberg, S. M. (2011) · Annals of Neurology · doi:10.1002/ana.22516 · Cited by 643 · see citing works

Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy

Greenberg, S. M., Rebeck, G. W., Vonsattel, J. P., Gómez‐Isla, T., & Hyman, B. T. (1995) · Annals of Neurology · doi:10.1002/ana.410380219 · Cited by 540 · see citing works

Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy

Grabowski, T. J., Cho, H. S., Vonsattel, J. P. G., Rebeck, G. W., & Greenberg, S. M. (2001) · Annals of Neurology · doi:10.1002/ana.1009 · Cited by 523 · see citing works

Cerebral Hemorrhage After Passive Anti-Aβ Immunotherapy

Pfeifer, M., Boncristiano, S., Bondolfi, L., Stalder, A., Deller, T., Staufenbiel, M., Mathews, P. M., & Jucker, M. (2002) · Science · doi:10.1126/science.1078259 · Cited by 511 · see citing works

Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology

Bard, F., Barbour, R., Cannon, C., Carretto, R., Fox, M., Games, D., Guido, T., Hoenow, K., Hu, K., Johnson-Wood, K., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0436286100 · Cited by 411 · see citing works

Diagnostic Criteria for Neuropathologic Assessment of Alzheimer’s Disease

Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00062-6 · Cited by 410 · see citing works

Microinfarct Pathology, Dementia, and Cognitive Systems

Arvanitakis, Z., Leurgans, S. E., Barnes, L. L., Bennett, D. A., & Schneider, J. A. (2011) · Stroke · doi:10.1161/strokeaha.110.595082 · Cited by 404 · see citing works

Cerebral amyloid angiopathy pathology and cognitive domains in older persons

Arvanitakis, Z., Leurgans, S. E., Wang, Z., Wilson, R. S., Bennett, D. A., & Schneider, J. A. (2011) · Annals of Neurology · doi:10.1002/ana.22112 · Cited by 383 · see citing works

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Premkumar, D. R., Cohen, D., Hedera, P., Friedland, R. P., & Kalaria, R. N. (1996) · Europe PMC (PubMed Central) · Cited by 345 · see citing works

Clinicopathologic Correlations in a Large Alzheimer Disease Center Autopsy Cohort: Neuritic Plaques and Neurofibrillary Tangles "Do Count" When Staging Disease Severity

Nelson, P. T., Jicha, G. A., Schmitt, F. A., Liu, H., Davis, D. G., Mendiondo, M. S., Abner, E. L., & Markesbery, W. R. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31815c5efb · Cited by 292 · see citing works

Variants at APOE influence risk of deep and lobar intracerebral hemorrhage

Biffi, A., Sonni, A., Anderson, C. D., D, B. M. K. M., Jagiella, J. M., Schmidt, H., Jiménez-Conde, J., Hansen, B. M., Fernández‐Cadenas, I., Cortellini, L., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22134 · Cited by 278 · see citing works

Human<i>APOE</i>Isoform-Dependent Effects on Brain β-Amyloid Levels in PDAPP Transgenic Mice

Bales, K. R., Liu, F., Wu, S., Lin, S., Koger, D., DeLong, C., Hansen, J. C., Sullivan, P. M., & Paul, S. M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0887-09.2009 · Cited by 274 · see citing works

Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy

Greenberg, S. M., Vonsattel, J.-P. G., Segal, A. Z., Chiu, R. I., Clatworthy, A. E., Liao, A., Hyman, B. T., & Rebeck, G. W. (1998) · Neurology · doi:10.1212/wnl.50.4.961 · Cited by 267 · see citing works

Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease

Nagy, Z. S., Esiri, M. M., Jobst, K. A., Johnston, C., Litchfield, S., Sim, E., & Smith, A. D. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00331-c · Cited by 250 · see citing works

Pathogenic Effects of D23N Iowa Mutant Amyloid β-Protein

Nostrand, W. E. V., Melchor, J. P., Cho, H. S., Greenberg, S. M., & Rebeck, G. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104135200 · Cited by 246 · see citing works

The genetics and neuropathology of Alzheimer’s disease

Schellenberg, G. D., & Montine, T. J. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0996-2 · Cited by 242 · see citing works

Modeling the Association between 43 Different Clinical and Pathological Variables and the Severity of Cognitive Impairment in a Large Autopsy Cohort of Elderly Persons

Nelson, P. T., Abner, E. L., Schmitt, F. A., Kryscio, R. J., Jicha, G. A., Smith, C. D., Davis, D. G., Poduska, J. W., Patel, E., Mendiondo, M. S., et al. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00244.x · Cited by 239 · see citing works

The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant

Olichney, J. M., Hansen, L. A., Galasko, D., Saitoh, T., Hofstetter, C. R., Katzman, R., & Thal, L. J. (1996) · Neurology · doi:10.1212/wnl.47.1.190 · Cited by 216 · see citing works

Neuroinflammatory phenotype in early Alzheimer's disease

Sudduth, T. L., Schmitt, F. A., Nelson, P. T., & Wilcock, D. M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.09.012 · Cited by 194 · see citing works

Mechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular Models

Herzig, M. C., Nostrand, W. E. V., & Jucker, M. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.tb00560.x · Cited by 167 · see citing works

The Apolipoprotein E ε2 Allele and the Pathological Features in Cerebral Amyloid Angiopathy-related Hemorrhage

McCarron, M. O., Nicoll, J. A. R., Stewart, J., Ironside, J. W., Mann, D. M. A., Love, S., Graham, D. I., & Dewar, D. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199907000-00005 · Cited by 160 · see citing works

Apolipoprotein E Markedly Facilitates Age-Dependent Cerebral Amyloid Angiopathy and Spontaneous Hemorrhage in Amyloid Precursor Protein Transgenic Mice

Fryer, J. D., Taylor, J. W., DeMattos, R. B., Bales, K. R., Paul, S. M., Parsadanian, M., & Holtzman, D. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07889.2003 · Cited by 160 · see citing works

Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis

Boche, D., Denham, N., Holmes, C., & Nicoll, J. A. R. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0719-5 · Cited by 135 · see citing works

Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.

Coria, F., Castaño, E. M., & Frangione, B. (1987) · PubMed Central · Cited by 120 · see citing works

Association of <i>HFE</i> mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with <i>APOE</i>

Pulliam, J. F., Jennings, C. D., Kryscio, R. J., Davis, D. G., Wilson, D., Montine, T. J., Schmitt, F. A., & Markesbery, W. R. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10069 · Cited by 89 · see citing works

High frequency of apolipoprotein E ε2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy

Nicoll, J. A. R., Burnett, C., Love, S., Graham, D. I., Ironside, J. W., & Vinters, H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390521 · Cited by 74 · see citing works

Amyloid‐β: A vascular sealant that protects against hemorrhage?

Atwood, C. S., Bishop, G. M., Perry, G., & Smith, M. A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10388 · Cited by 44 · see citing works

Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains

Pirttilä, T., Soininen, H. S., Mehta, P. D., Heinonen, O., Lehtimäki, T. J., Bogdanović, N., Paljärvi, L., Kim, K. S., Kosunen, O., Winblad, B. G., et al. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00204-7 · Cited by 33 · see citing works

Human Apolipoprotein E4 Targeted Replacement Mice Show Increased Prevalence of Intracerebral Hemorrhage Associated with Vascular Amyloid Deposition

Sullivan, P. M., Mace, B. E., Estrada, J. C., Schmechel, D. E., & Alberts, M. J. (2008) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2008.03.011 · Cited by 30 · see citing works

Human Apolipoprotein E Redistributes Fibrillar Amyloid Deposition in Tg-SwDI Mice

Xu, F., Vitek, M. P., Colton, C. A., Previti, M. L., Gharkholonarehe, N., Davis, J., & Nostrand, W. E. V. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1042-08.2008 · Cited by 27 · see citing works

Clinical trial methodologies for disease-modifying therapeutic approaches

Aisen, P. S. S. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.008 · Cited by 16 · see citing works

Human Apolipoprotein E2 Promotes Parenchymal Amyloid Deposition and Neuronal Loss in Vasculotropic Mutant Amyloid-β Protein Tg-SwDI Mice

Xu, F., Vitek, M. P., Colton, C. A., Previti, M. L., Davis, J., & Nostrand, W. E. V. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120421 · Cited by 8 · see citing works

Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.

(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2 · see citing works

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies

Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C.-C., & Bu, G. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0228-7 · Cited by 1,425 · see citing works

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

Raulin, A.-C., Doss, S. V., Trottier, Z. A., Ikezu, T. C., Bu, G., & Liu, C.-C. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00574-4 · Cited by 756 · see citing works

The overlap between vascular disease and Alzheimer’s disease - lessons from pathology

Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739 · see citing works

The neuropathology and cerebrovascular mechanisms of dementia

Raz, L., Knoefel, J. E., & Bhaskar, K. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.164 · Cited by 470 · see citing works

Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer’s disease.

Sadick, J. S., O’Dea, M. R., Hasel, P., Dykstra, T., Faustin, A., & Liddelow, S. A. (2022) · Neuron · doi:10.1016/j.neuron.2022.03.008 · Cited by 415 · see citing works

Alzheimer's disease: From immunotherapy to immunoprevention

Jucker, M., & Walker, L. C. (2023) · Cell · doi:10.1016/j.cell.2023.08.021 · Cited by 353 · see citing works

APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease

Li, Z., Shue, F., Zhao, N., Shinohara, M., & Bu, G. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00413-4 · Cited by 306 · see citing works

The neuroimmune axis of Alzheimer’s disease

Jorfi, M., Maaser‐Hecker, A., & Tanzi, R. E. (2023) · Genome Medicine · doi:10.1186/s13073-023-01155-w · Cited by 299 · see citing works

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases

Fernández-Calle, R., Konings, S. C., Frontiñán-Rubio, J., García-Revilla, J., Camprubí-Ferrer, L., Svensson, M., Martinson, I., Boza-Serrano, A., Venero, J. L., Nielsen, H. M., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00566-4 · Cited by 278 · see citing works

APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease

Parhizkar, S., & Holtzman, D. M. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101594 · Cited by 255 · see citing works

The role of APOE in cerebrovascular dysfunction

Tai, L. M., Thomas, R., Marottoli, F. M., Koster, K. P., Kanekiyo, T., Morris, A. W. J., & Bu, G. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1547-z · Cited by 231 · see citing works

Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins

Huynh, T.-P. V., Davis, A. A., Ulrich, J. D., & Holtzman, D. M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075481 · Cited by 210 · see citing works

Aducanumab: Appropriate Use Recommendations Update

Cummings, J. L., Rabinovici, G. D., Atri, A., Aisen, P. S. S., Apostolova, L. G., Hendrix, S. B., Sabbagh, M. N., Selkoe, D. J., Weiner, M. W., & Salloway, S. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.34 · Cited by 198 · see citing works

Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease

Liao, F., Yoon, H., & Kim, J. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000383 · Cited by 191 · see citing works

Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy

Reijmer, Y. D., Fotiadis, P., Martinez-Ramirez, S., Salat, D. H., Schultz, A., Shoamanesh, A., Ayres, A. M., Vashkevich, A., Rosas, D., Schwab, K., et al. (2015) · Brain · doi:10.1093/brain/awu316 · Cited by 181 · see citing works

Alzheimer's Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function

Battista, A. M. D., Heinsinger, N. M., & Rebeck, G. W. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160401115127 · Cited by 184 · see citing works

Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes

Brenowitz, W. D., Nelson, P. T., Besser, L. M., Heller, K., & Kukull, W. A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.028 · Cited by 174 · see citing works

Late-Onset Alzheimer’s Disease Genes and the Potentially Implicated Pathways

Rosenthal, S. L., & Kamboh, M. I. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0034-x · Cited by 153 · see citing works

The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer’s Disease

Kloske, C. M., & Wilcock, D. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00754 · Cited by 152 · see citing works

Canine Cognitive Dysfunction and Alzheimer’s Disease – Two Facets of the Same Disease?

Mihevc, S. P., & Majdič, G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00604 · Cited by 138 · see citing works

The exchangeable apolipoproteins in lipid metabolism and obesity

Su, X., & Peng, D. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.01.015 · Cited by 136 · see citing works

The interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals

Osorio, R. S., Ayappa, I. A., Mantua, J., Gumb, T., Varga, A. W., Mooney, A. M., Burschtin, O. E., Taxin, Z. H., During, E., Spector, N. C., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.030 · Cited by 123 · see citing works

APOE and cerebral amyloid angiopathy in community-dwelling older persons

Yu, L., Boyle, P. A., Nag, S., Leurgans, S., Buchman, A. S., Wilson, R. S., Arvanitakis, Z., Farfel, J. M., De Jager, P. L., Bennett, D. A., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.008 · Cited by 123 · see citing works

Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer’s disease

Shinohara, M., Murray, M. E., Frank, R. D., Shinohara, M., DeTure, M., Yamazaki, Y., Tachibana, M., Atagi, Y., Davis, M. D., Liu, C.-C., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1580-y · Cited by 123 · see citing works

The informed road map to prevention of Alzheimer Disease: a call to arms

McDade, E., Llibre-Guerra, J. J., Holtzman, D. M., Morris, J. C., & Bateman, R. J. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00467-y · Cited by 89 · see citing works

Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy

Duong, M. T., Nasrallah, I. M., Wolk, D. A., Chang, C. C. Y., & Chang, T. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.647990 · Cited by 106 · see citing works

High-Density Lipoproteins and Cerebrovascular Integrity in Alzheimer’s Disease

Stukas, S. K., Robert, J., & Wellington, C. L. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.003 · Cited by 96 · see citing works

Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets

Kwon, S., Iba, M., Kim, C., & Masliah, E. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00853-2 · Cited by 92 · see citing works

The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice

Cacciottolo, M., Christensen, A., Moser, V. A., Liu, J., Pike, C. J., Smith, C. C., LaDu, M. J., Sullivan, P. M., Morgan, T. E., Dolzhenko, E., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.010 · Cited by 94 · see citing works

Vascular Risk Factors and Alzheimer’s Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links

He, J., Zhao, X., Xu, L., & Mao, C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190764 · Cited by 86 · see citing works

White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease

Soldan, A., Pettigrew, C. A., Zhu, Y., Wang, M., Moghekar, A., Gottesman, R. F., Singh, B., Martinez, O., Fletcher, E. M., DeCarli, C. S., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008864 · Cited by 82 · see citing works

Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals

Ighodaro, E. T., Abner, E. L., Fardo, D. W., Lin, A.-L., Katsumata, Y., Schmitt, F. A., Kryscio, R. J., Jicha, G. A., Neltner, J. H., Monsell, S. E., et al. (2017) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1177/0271678x15621574 · Cited by 98 · see citing works

Neuropathology of Anti-Amyloid-β Immunotherapy: A Case Report

Castellani, R. J., Shanes, E. D., McCord, M., Reish, N. J., Flanagan, M. E., Mesulam, M. M., & Jamshidi, P. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221305 · Cited by 84 · see citing works

Brain microvascular injury and white matter disease provoked by diabetes‐associated hyperamylinemia

Ly, H., Verma, N., Wu, F., Liu, M., Saatman, K. E., Nelson, P. T., Slevin, J. T., Goldstein, L. B., Biessels, G. J., & Despa, F. (2017) · Annals of Neurology · doi:10.1002/ana.24992 · Cited by 79 · see citing works

Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models

Liao, F., Zhang, T. J., Jiang, H., Lefton, K. B., Robinson, G. O., Vassar, R., Sullivan, P. M., & Holtzman, D. M. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0250-y · Cited by 77 · see citing works

Exploring cerebral amyloid angiopathy: Insights into pathogenesis, diagnosis, and treatment

Cozza, M., Amadori, L., & Boccardi, V. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120866 · Cited by 84 · see citing works

APOE effects on regional tau in preclinical Alzheimer’s disease

Young, C. B., Johns, E., Kennedy, G., Belloy, M. E., Insel, P. S., Greicius, M. D., Sperling, R. A., Johnson, K. A., Poston, K. L., Mormino, E. C., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00590-4 · Cited by 80 · see citing works

Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells

Rieker, C., Migliavacca, E., Vaucher, A., Mayer, F. C., Baud, G., Marquis, J., Charpagne, A., Hegde, N., Guignard, L., McLachlan, M. J., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.312261 · Cited by 59 · see citing works

The spectrum of preclinical Alzheimer's disease pathology and its modulation by ApoE genotype

Pletniková, O., Kageyama, Y., Rudow, G. L., LaClair, K. D., Albert, M., Crain, B. J., Tian, J., Fowler, D. R., & Troncoso, J. C. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.07.007 · Cited by 56 · see citing works

Cerebral Amyloid Angiopathy, Subcortical White Matter Disease and Dementia: Literature Review and Study in OPTIMA

Esiri, M. M., Chance, S. A., Joachim, C. L., Warden, D. R., Smallwood, A., Sloan, C., Christie, S., Wilcock, G. K., & Smith, A. D. (2014) · Brain Pathology · doi:10.1111/bpa.12221 · Cited by 55 · see citing works

Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis

Nelson, P. T., Fardo, D. W., Wu, X., Aung, K. Z., Cykowski, M. D., & Katsumata, Y. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae032 · Cited by 52 · see citing works

Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer’s Disease

Helman, A. M., Siever, M., McCarty, K. L., Lott, I. T., Doran, E. W., Abner, E. L., Schmitt, F. A., & Head, E. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180589 · Cited by 49 · see citing works

Fine-mapping the effects of Alzheimer's disease risk loci on brain morphology

Roshchupkin, G. V., Adams, H. H. H., van der Lee, S. J., Vernooij, M. W., van Duijn, C. M., Uitterlinden, A. G., van der Lugt, A., Albert Hofman, D., Niessen, W. J., & Ikram, M. A. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.024 · Cited by 45 · see citing works

Diffuse Amyloid- β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons’ Brains Lacking Neuritic Amyloid Plaques

Abner, E. L., Neltner, J. H., Jicha, G. A., Patel, E., Anderson, S., Wilcock, D. M., Eldik, L. J. V., & Nelson, P. T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180514 · Cited by 42 · see citing works

Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy

Xiong, M., Wang, C., Gratuze, M., Saadi, F., Bao, X., Bosch, M. E., Lee, C., Jiang, H., Serrano, J. R., Gonzales, E. R., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00610-x · Cited by 41 · see citing works

Apolipoprotein E Genotype e2: Neuroprotection and Its Limits

Kim, H., Devanand, D. P., Carlson, S., & Goldberg, T. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.919712 · Cited by 36 · see citing works

The vascular contribution of apolipoprotein E to Alzheimer’s disease

Chen, F., Zhao, J., Meng, F., He, F., Ni, J., & Fu, Y. (2024) · Brain · doi:10.1093/brain/awae156 · Cited by 38 · see citing works

Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson’s disease dementia

Hansen, D., Ling, H., Lashley, T., Foley, J. A., Strand, C., Eid, T. M., Holton, J. L., & Warner, T. T. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12648 · Cited by 37 · see citing works

APOE ɛ 2 is associated with white matter hyperintensity volume in CADASIL

Gesierich, B. G., Opherk, C., Rosand, J. M., Gonik, M., Malik, R., Jouvent, É., Hervé, D., Adib‐Samii, P., Bevan, S., Pianese, L., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.85 · Cited by 35 · see citing works

The NLRP3 inflammasome as a bridge between neuro-inflammation in metabolic and neurodegenerative diseases

Söderbom, G., & Zeng, B. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.023 · Cited by 31 · see citing works

Social determinants of health but not global genetic ancestry predict dementia prevalence in Latin America

Llibre‐Guerra, J. J., Jiang, M., Acosta, I., Sosa, A. L., Acosta, D. M., Jimenez‐Velasquez, I. Z., Guerra, M., Salas, A., Salgado, A. M. R., Llibre‐Guerra, J. C., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14041 · Cited by 29 · see citing works

APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer’s disease and age-matched non-demented brains

Ojo, J. O., Reed, J. M., Crynen, G. C., Vallabhaneni, P., Evans, J., Shackleton, B., Eisenbaum, M., Ringland, C., Edsell, A., MULLAN, M. J., et al. (2021) · Molecular Brain · doi:10.1186/s13041-021-00803-9 · Cited by 29 · see citing works

<i>APOE</i> genotypes as a risk factor for age‐dependent accumulation of cerebrovascular disease in older adults

Lamar, M., Yu, L., Rubin, L. H., James, B. D., Barnes, L. L., Farfel, J. M., Gaiteri, C., Buchman, A. S., Bennett, D. A., & Schneider, J. A. (2019) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2018.08.007 · Cited by 27 · see citing works

Age-at-Onset and <i>APOE</i> -Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer Disease

Smirnov, D. S., Galasko, D., Hiniker, A., Edland, S. D., & Salmon, D. P. (2021) · Neurology · doi:10.1212/wnl.0000000000011772 · Cited by 25 · see citing works

Racial/ethnic variation of APOE alleles for lobar intracerebral hemorrhage

Sawyer, R. P., Sekar, P., Osborne, J., Kittner, S. J., Moomaw, C. J., Flaherty, M. L., Langefeld, C. D., Anderson, C. D., Rosand, J. M., & Woo, D. (2018) · Neurology · doi:10.1212/wnl.0000000000005908 · Cited by 26 · see citing works

Sex differences in a murine model of Cerebral Amyloid Angiopathy

Maniskas, M. E., Mack, A. F., Morales‐Scheihing, D., Finger, C. E., Zhu, L., Paulter, R., Urayama, A., McCullough, L. D., & Manwani, B. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100260 · Cited by 25 · see citing works

Aβ efflux impairment and inflammation linked to cerebrovascular accumulation of amyloid-forming amylin secreted from pancreas

Verma, N., Velmurugan, G. V., Winford, E. D., Ly, H., Kotiya, D., Leibold, N. S., Radulescu, L., Despa, S. I., Chen, K. C., Eldik, L. J. V., et al. (2023) · Communications Biology · doi:10.1038/s42003-022-04398-2 · Cited by 25 · see citing works

Vascular Dysfunction Is Central to Alzheimer’s Disease Pathogenesis in APOE e4 Carriers

McCorkindale, A. N., Mundell, H. D., Guennewig, B., & Sutherland, G. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137106 · Cited by 22 · see citing works

Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy

Ojo, J. O., Reed, J. M., Crynen, G. C., Vallabhaneni, P., Evans, J., Shackleton, B., Eisenbaum, M., Ringland, C., Edsell, A., MULLAN, M. J., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.658605 · Cited by 21 · see citing works

Pathologic sequelae of vascular cognitive impairment and dementia sheds light on potential targets for intervention

Linton, A. E., Weekman, E. M., & Wilcock, D. (2021) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2021.100030 · Cited by 22 · see citing works

Soluble Biomarkers of Cerebrovascular Pathologies

Foley, K. E., & Wilcock, D. M. (2024) · Stroke · doi:10.1161/strokeaha.123.044172 · Cited by 21 · see citing works

Impact of Apolipoprotein E ε4 in Alzheimer’s Disease: A Meta-Analysis of Voxel-Based Morphometry Studies

Bailey, M., Ilchovska, Z. G., Hosseini, A. A., & Jung, J. (2024) · Journal of Clinical Neurology · doi:10.3988/jcn.2024.0176 · Cited by 25 · see citing works

APOE4 to APOE2 allelic switching in mice improves Alzheimer’s disease-related metabolic signatures, neuropathology and cognition

Golden, L. R., Siano, D. S., Stephens, I. O., MacLean, S. M., Saito, K., Nolt, G. L., Funnell, J. L., Pallerla, A. V., Lee, S., Smith, C., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02094-y · Cited by 18 · see citing works

Deciphering the role of APOE in cerebral amyloid angiopathy: from genetic insights to therapeutic horizons

Hu, H., Wan, S., Hu, Y., Wang, Q., Li, H., & Zhang, N. (2025) · Annals of Medicine · doi:10.1080/07853890.2024.2445194 · Cited by 19 · see citing works

APOE and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Hemorrhage

Hostettler, I. C., Seiffge, D. J., Wong, A., Ambler, G., Wilson, D., Shakeshaft, C., Banerjee, G., Sharma, N., Jäger, H. R., Cohen, H., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200851 · Cited by 20 · see citing works

AD and non‐AD mediators of the pathway between the APOE genotype and cognition

Nichols, E. L., Brickman, A. M., Casaletto, K. B., Dams-O’Connor, K., George, K. M., Kumar, R. G., Palta, P., Rabin, J. S., Satizábal, C. L., Schneider, J. A., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12885 · Cited by 18 · see citing works

Apolipoprotein E Proteinopathy Is a Major Dementia-Associated Pathologic Biomarker in Individuals with or without the APOE Epsilon 4 Allele

Gal, J., Katsumata, Y., Zhu, H., Srinivasan, S., Chen, J., Johnson, L. A., Wang, W.-X., Golden, L. R., Wilcock, D. M., Jicha, G. A., et al. (2022) · The American Journal of Pathology · doi:10.1016/j.ajpath.2021.11.013 · Cited by 17 · see citing works

Relationship of Apolipoprotein E with Alzheimer’s Disease and Other Neurological Disorders: An Updated Review

Lou, T.-W., Tao, B., & Chen, M. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.01.032 · Cited by 16 · see citing works

Two cases of Amyloid-Related Imaging Abnormalities (ARIA) following lecanemab treatment for alzheimer’s disease and a literature review

Wang, Y., Yu, Q., Chen, B., Zhou, J., Li, Z., Liao, W., Liu, J., & Yang, A. (2025) · BMC Neurology · doi:10.1186/s12883-025-04302-5 · Cited by 15 · see citing works

Association between APOE-ε4 allele and cognitive function is mediated by Alzheimer’s disease pathology: a population-based autopsy study in an admixed sample

Paradela, R. S., Justo, A. F. O., Paes, V. R., Leite, R. E. P., Pasqualucci, C. A., Grinberg, L. T., Naslavsky, M. S., Zatz, M., Nitríni, R., Filho, W. J., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01681-z · Cited by 16 · see citing works

Autopsy of a multiple lobar hemorrhage case with amyloid‐β‐related angiitis

Ichimata, S., Hata, Y., Yoshida, K., & Nishida, N. (2020) · Neuropathology · doi:10.1111/neup.12637 · Cited by 15 · see citing works

Associations of APOE e2 genotype with cerebrovascular pathology: a postmortem study of 1275 brains

Goldberg, T. E., Huey, E. D., & Devanand, D. P. (2021) · Journal of Neurology, Neurosurgery &amp; Psychiatry · doi:10.1136/jnnp-2020-323746 · Cited by 19 · see citing works

Unifying Vascular Injury and Neurodegeneration: A Mechanistic Continuum in Cerebral Small Vessel Disease and Dementia

Jin, C., & Bhaskar, S. M. M. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70246 · Cited by 14 · see citing works

The impact of Apolipoprotein E alleles on cognitive performance in patients with Parkinson's disease

Pierzchlińska, A., Białecka, M. A., Kurzawski, M., & Sławek, J. W. (2018) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2018.04.003 · Cited by 14 · see citing works

Reduced Influence of apoE on Aβ43 Aggregation and Reduced Vascular Aβ43 Toxicity as Compared with Aβ40 and Aβ42

Jäkel, L., Biemans, E. A. L. M., Klijn, C. J. M., Kuiperij, H. B., & Verbeek, M. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01873-x · Cited by 14 · see citing works

Neuropathologic Assessment of Dementia Markers in Identical and Fraternal Twins

Iacono, D., Volkmann, I., Nennesmo, I., Pedersen, N. L., Fratiglioni, L., Johansson, B. E. A., Karlsson, D., Winblad, B. G., & Gatz, M. (2014) · Brain Pathology · doi:10.1111/bpa.12127 · Cited by 14 · see citing works

Intracerebral hemorrhage following mild ARIA-H in an APOE ε2 carrier receiving lecanemab

Ji, S.-M., & Rosenbloom, M. H. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01640-3 · Cited by 13 · see citing works

Rapid, scalable assay of amylin-β amyloid co-aggregation in brain tissue and blood

Kotiya, D., Leibold, N. S., Verma, N., Jicha, G. A., Goldstein, L. B., & Despa, F. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104682 · Cited by 12 · see citing works

Molecular Mechanisms Underlying Amyloid Beta Peptide Mediated Upregulation of Vascular Cell Adhesion Molecule-1 in Alzheimer Disease

Salian, V. S., Tang, X., Thompson, K. J., Curran, G. L., Lowe, V. J., Li, L., Kalari, K. R., & Kandimalla, K. K. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.124.002280 · Cited by 14 · see citing works

Inflammation and DNA methylation in Alzheimer’s disease: mechanisms of epigenetic remodelling by immune cell oxidants in the ageing brain

Seddon, A. R., MacArthur, C. P., Hampton, M. B., & Stevens, A. J. (2024) · Redox Report · doi:10.1080/13510002.2024.2428152 · Cited by 11 · see citing works

Cerebral Amyloid Angiopathy, Dementia, and Alzheimer Neuropathologic Changes

Sin, M., Cheng, Y., Ahmed, A., Roseman, J. M., Dowling, N. M., & ZAMRINI, E. Y. (2024) · Neurology · doi:10.1212/wnl.0000000000210009 · Cited by 10 · see citing works

Vascular Cognitive Impairment

Silbert, L. C. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001508 · Cited by 11 · see citing works

The PSEN1 E280G mutation leads to increased amyloid-β43 production in induced pluripotent stem cell neurons and deposition in brain tissue

Willumsen, N., Arber, C., Lovejoy, C. E. J., Toombs, J., Alatza, A., Weston, P. S. J., Chávez‐Gutiérrez, L., Hardy, J., Zetterberg, H., Fox, N. C., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac321 · Cited by 10 · see citing works

A case of amyloid-β-related cerebral angiitis with ApoE ε4/ε2 genotype

Ogura, A., Moriyoshi, H., Nakai, N., Nishida, S., Kitagawa, S., Yoshida, M., Yasuda, T., & Ito, Y. (2015) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-000685 · Cited by 9 · see citing works

APOE Genotype Alters Immunoglobulin Subtypes in Knock-In Mice

Zhou, Y., Zhao, W., Al‐Muhtasib, N., & Rebeck, G. W. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142184 · Cited by 9 · see citing works

Developing and validating a prediction tool for cerebral amyloid angiopathy neuropathological severity

Chu, C., Wang, Y., Ma, L., Mutimer, C. A., Ji, G., Shi, H., Yassi, N., Masters, C. L., Goudey, B., Jin, L., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14583 · Cited by 8 · see citing works

Association between APOE ε2 and Aβ burden in patients with Alzheimer- and vascular-type cognitive impairment

Lee, J. S., Lee, H., Park, S., Choe, Y. S., Park, Y. H., Cheon, B. K., Hahn, A., Ossenkoppele, R., Kim, H. J., Kim, S., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010811 · Cited by 8 · see citing works

Advances of therapeutic strategies for Alzheimer’s disease

Guo, X., Yue, R.-Z., Cui, Z., Wang, S., Jia, T., Li, W., Zhang, W., Shan, L., & Li, C. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13456-8 · Cited by 8 · see citing works

APOE alleles are associated with sex-specific structural differences in brain regions affected in Alzheimer’s disease and related dementia

Savignac, C., Villeneuve, S., Badhwar, A., Saltoun, K., Shafighi, K., Zajner, C., Sharma, V., Taliun, S. A. G., Farhan, S. M. K., Poirier, J., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001863 · Cited by 10 · see citing works

Therapeutic Challenges Derived from the Interaction Among Apolipoprotein E, Cholesterol, and Amyloid in Alzheimer’s Disease

Menéndez‐González, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212029 · Cited by 7 · see citing works

Mouse models of Anti-Aβ immunotherapies

Pikus, P., Turner, R. S., & Rebeck, G. W. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00836-x · Cited by 6 · see citing works

APOE genotype influences on the brain metabolome of aging mice - role for mitochondrial energetics in mechanisms of resilience in APOE2 genotype

Borkowski, K., Liang, N., Zhao, N., Arnold, M., Huynh, K., Karu, N., Mahmoudiandehkordi, S., Kueider-Paisley, A., Kanekiyo, T., Bu, G., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00888-z · Cited by 7 · see citing works

Effects of APOE e4 and Neuropathological Diagnoses on Neuropsychiatric Symptoms: Mediation Analyses and Likely Causation in an Integrated NACC Database

Goldberg, T. E., Devanand, D. P., Fang, Z., Kim, H., Rueppel, E., Tucker, A., Carlson, S., & Lee, S. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.01.012 · Cited by 6 · see citing works

Vascular Heparan Sulfate and Amyloid-β in Alzheimer’s Disease Patients

McMillan, I. O., Gearing, M., & Wang, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073964 · Cited by 6 · see citing works

A Case of Cerebral Amyloid Angiopathy-Related Inflammation With the Rare Apolipoprotein ε2/ε2 Genotype

Xu, Y., Chen, D., Zhao, J., Chen, X., & Zhang, J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00547 · Cited by 6 · see citing works

Association of Apolipoprotein E4-related Microvascular Disease in the Alzheimer’s Disease Hippocampal CA1 Stratum Radiatum

Wang, H., Zhang, Z., Sittirattanayeunyong, S., & Hongpaisan, J. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.06.019 · Cited by 6 · see citing works

Visual‐somatosensory integration as a novel behavioral marker of amyloid pathology

Mahoney, J. R., Ayers, E. I., & Verghese, J. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14561 · Cited by 5 · see citing works

APOE4, oxidative stress and decreased repair capacity - a no-brainer. Faulty lipid metabolism and increased levels of oxidative damage may be risk factors in the pathogenesis of late-onset dementia

Nayyar, A., & Chakalova, L. (2015) · Biodiscovery · doi:10.7750/biodiscovery.2015.17.1 · Cited by 4 · see citing works

The impact of APOE ε4 in Alzheimer’s disease: a meta-analysis of voxel-based morphometry studiesPreprint

Bailey, M., Ilchovska, Z. G., Hosseini, A. A., & Jung, J. (2024) · medRxiv · doi:10.1101/2024.05.10.24307165 · Cited by 5 · see citing works

An update on emerging anti-amyloid-β monoclonal antibodies for treating Alzheimer’s disease: the role of apolipoprotein E

Lozupone, M., Dibello, V., Daniele, A., & Panza, F. (2025) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2025.2481847 · Cited by 5 · see citing works

<i>APOE</i>ɛ4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Aβ protein

Chalmers, K., Wilcock, G. K., & Love, S. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00457.x · Cited by 156 · see citing works

The distribution of cerebrovascular amyloid in Alzheimer’s disease varies with ApoE genotype

Trembath, D., Ervin, J. F., Broom, L., Szymanski, M., Welsh-Bohmer, K., Pieper, C., & Hulette, C. M. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0162-9 · Cited by 31 · see citing works

French protest at health budget cuts

Dorozynski, A. (1995) · BMJ · doi:10.1136/bmj.311.7015.1247a · Cited by 3 · see citing works

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Premkumar, D. R., Cohen, D., Hedera, P., Friedland, R. P., & Kalaria, R. N. (1996) · Europe PMC (PubMed Central) · Cited by 345 · see citing works

APOE and cerebral amyloid angiopathy in community-dwelling older persons

Yu, L., Boyle, P. A., Nag, S., Leurgans, S., Buchman, A. S., Wilson, R. S., Arvanitakis, Z., Farfel, J. M., De Jager, P. L., Bennett, D. A., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.008 · Cited by 123 · see citing works